RT Book, Section A1 Friedman, Lawrence S. A2 Papadakis, Maxine A. A2 McPhee, Stephen J. A2 Rabow, Michael W. A2 McQuaid, Kenneth R. SR Print(0) ID 1193152448 T1 Nonalcoholic Fatty Liver Disease T2 Current Medical Diagnosis & Treatment 2023 YR 2023 FD 2023 PB McGraw-Hill Education PP New York, NY SN 9781264687343 LK accessmedicine.mhmedical.com/content.aspx?aid=1193152448 RD 2024/10/07 AB Key Clinical Updates in Nonalcoholic Fatty Liver DiseaseNoninvasive approaches to the assessment of fibrosis are now preferred, with liver biopsy reserved when results of noninvasive testing are inconclusive. The FIB-4 score is often used particularly to exclude advanced fibrosis because of its simplicity. It is based on age, platelet count, and serum AST and ALT levels.Younossi ZM et al. Am J Gastroenterol. [PMID: 33284184]